ATRA vs BRO · rev $128.9M vs P/E 30, rev $4.80B
Atara Biotherapeutics Inc (ATRA) versus Brown & Brown Inc (BRO) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Brown & Brown Inc (BRO) is a insurance brokers company listed on US.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported BRO revenue for 2024-12-31 was $4.80B. Net income was $1.00B. Revenue was up 12.9% from 2023-12-31 to 2024-12-31. BRO currently screens at market cap $35.56B and trailing P/E 30.0.
ATRA currently screens at market cap $87.1M. BRO currently screens at market cap $35.56B and trailing P/E 30.0.
Not investment advice. Open the ATRA and BRO stock pages for the full models.
Not investment advice.